Study of Platelet Population Changes Under Circulatory Support With ECMO
NCT07334457 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2026-01-12
Summary
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
Conditions
- Cardiac Failure
- Respiratory Failure
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-11
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-11
Countries
- France
Study Locations
More Related Trials
-
Platelet Agregation in Patients on ECMO
NCT05542134 ·Status: UNKNOWN
-
Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy
NCT04366752 ·Status: COMPLETED
-
Thrombo-Elastography Guided Management of ECMO
NCT04268940 ·Status: COMPLETED
-
Interest in Evaluating Primary Hemostasis in Patients With Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
NCT03248596 ·Status: TERMINATED
-
Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
NCT03773159 ·Status: RECRUITING
-
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
NCT04377490 ·Status: RECRUITING
-
Detecting Circulating Emboli in Patients with Acute Venous Thromboembolism
NCT02735759 ·Status: WITHDRAWN ·Phase: NA
-
Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
NCT04757129 ·Status: RECRUITING
-
Thromboembolic Events in Severe COVID-19 Patients
NCT04405869 ·Status: UNKNOWN
-
Prevalence of Pulmonary Embolism in ICU
NCT01457963 ·Status: COMPLETED
-
Evaluation of New Biomarkers of Thrombosis in Myeloproliferative Neoplasms
NCT04177576 ·Status: COMPLETED
-
Association Between the Level of EV-TF and the Occurence of Pulmonary Embolism in Patients With ARDS
NCT05855317 ·Status: RECRUITING
-
Pulmonary Perfusion Heterogeneity in Patients With CTEPH Using Functional PET Imaging
NCT02114047 ·Status: COMPLETED
-
Exploratory Metabolomics Study of Exhaled Breath in Pulmonary Embolism
NCT04001179 ·Status: TERMINATED
-
Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence
NCT01078792 ·Status: UNKNOWN
-
Evaluation of Soluble Fibrin in Thrombosis Exclusion
NCT02523937 ·Status: COMPLETED
-
Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms
NCT04420312 ·Status: COMPLETED
-
Pulmonary Embolism as a Cause of COPD Exacerbations
NCT02238639 ·Status: COMPLETED ·Phase: NA
-
Hemopatch Performance Evaluation: A Prospective Observational Registry
NCT03392662 ·Status: COMPLETED
-
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease
NCT04479540 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Performance of Magneto PE Kit
NCT04949048 ·Status: COMPLETED ·Phase: NA
-
Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
NCT01626521 ·Status: UNKNOWN
-
Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO)
NCT00831259 ·Status: COMPLETED
-
Prognostic Tools in Patients With Acute Pulmonary Thromboembolism.
NCT04237974 ·Status: UNKNOWN
-
Pulmonary Embolism and PCT. PE-PCT Study
NCT02261610 ·Status: TERMINATED ·Phase: NA